News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis AG (NVS) Has A History Of Charging High Prices For Drugs In Colombia



11/2/2016 6:48:36 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
For the past four years, Novartis has refuted charges of unfairly pricing a key cancer treatment in Colombia. Internal company data show, though, that the drug maker had also charged much more in the Latin American nation for three other widely used medicines than in dozens of other countries.

In 2013, the most recent year for which data was obtained, Novartis charged at least 58 percent to 626 percent more for 30 tablets of the Exforge high blood pressure medication than in 50 other countries, including high-income nations such as the United Kingdom and Germany. For instance, the price was $92.87 in Colombia, compared with $43.84 in Germany, $36.04 in the UK and $17.27 in Australia.

Read at STAT


comments powered by Disqus
STAT
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES